Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (6)
- (-) Polymers (1)
- (-) Summit (2)
- 3-D Printing/Advanced Manufacturing (3)
- Artificial Intelligence (3)
- Big Data (1)
- Bioenergy (8)
- Biology (17)
- Biotechnology (4)
- Chemical Sciences (2)
- Clean Water (3)
- Climate Change (1)
- Composites (1)
- Computer Science (7)
- Coronavirus (2)
- Decarbonization (1)
- Energy Storage (1)
- Environment (18)
- Exascale Computing (1)
- Fusion (1)
- High-Performance Computing (5)
- Materials (3)
- Materials Science (5)
- Mercury (3)
- Microscopy (2)
- Nanotechnology (3)
- Neutron Science (11)
- Nuclear Energy (1)
- Physics (1)
- Quantum Computing (1)
- Quantum Science (2)
- Security (1)
- Sustainable Energy (5)
- Transportation (1)
Media Contacts
Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers, according to a bibliometric analysis conducted by the scientific publication analytics firm Clarivate.
Improved data, models and analyses from ORNL scientists and many other researchers in the latest global climate assessment report provide new levels of certainty about what the future holds for the planet
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.